iSpecimen Inc.
ISPC
$1.25
$0.0352.88%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 9.29M | 10.39M | 10.51M | 9.27M | 9.93M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.29M | 10.39M | 10.51M | 9.27M | 9.93M |
| Cost of Revenue | 5.30M | 5.41M | 5.24M | 4.67M | 4.82M |
| Gross Profit | 3.99M | 4.99M | 5.26M | 4.59M | 5.11M |
| SG&A Expenses | 13.19M | 11.20M | 11.80M | 12.58M | 12.71M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.02M | 20.15M | 20.75M | 20.90M | 21.10M |
| Operating Income | -12.73M | -9.76M | -10.25M | -11.63M | -11.17M |
| Income Before Tax | -12.50M | -9.52M | -10.20M | -11.57M | -11.10M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.50 | -9.52 | -10.20 | -11.57 | -11.10 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.50M | -9.52M | -10.20M | -11.57M | -11.10M |
| EBIT | -12.73M | -9.76M | -10.25M | -11.63M | -11.17M |
| EBITDA | -12.47M | -9.50M | -10.03M | -11.44M | -11.00M |
| EPS Basic | -17.52 | -18.94 | -21.50 | -25.50 | -24.56 |
| Normalized Basic EPS | -10.95 | -11.84 | -13.44 | -15.94 | -15.35 |
| EPS Diluted | -17.52 | -18.94 | -21.50 | -25.50 | -24.56 |
| Normalized Diluted EPS | -10.95 | -11.84 | -13.44 | -15.94 | -15.35 |
| Average Basic Shares Outstanding | 2.84M | 2.16M | 1.93M | 1.82M | 1.81M |
| Average Diluted Shares Outstanding | 2.84M | 2.16M | 1.93M | 1.82M | 1.81M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |